Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeAutoimmune diseases

      Autoimmune diseases

      What’s the difference between IBS and IBD?

      These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

      What is IL-23?

      This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.

      Quiz: How much do you know about psoriasis?

      The chronic skin condition causes itchy and scaly patches, but it’s much more than simply a cosmetic concern. For World Psoriasis Day, take this quiz to test your psoriasis IQ—and learn why Johnson & Johnson is working on new and more effective treatments for this common autoimmune disease.

      Rheumatoid, psoriatic and osteoarthritis—what you need to know about the 3 main types of arthritis

      They share similar symptoms, sure. But these three distinct conditions have distinct causes, occur in people of varying ages and have their own treatments. Read on for the key differences.

      5 things we now know about myasthenia gravis

      For Myasthenia Gravis Awareness Month, discover more about the disease, learn how one woman lives with this rare autoantibody condition and why Johnson & Johnson is working to find new treatments for patients like her.

      “My battle with IBD has fueled my passion for helping patients like me”

      Sid Jain, a leader on the pharmaceutical R&D data science team at Johnson & Johnson, knows that new and better treatment options change lives. And being a Crohn’s disease patient himself has supercharged his mission to help revolutionize the research process.

      “My job is to educate about the need for new treatments for rare diseases”

      Hetal Patel, an immunodermatology medical director at Johnson & Johnson, forged her own career path—and now she’s living into her passion for advocacy, education and innovation.

      4 things scientists now know about autoimmune diseases in kids

      Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.

      The impact of COVID-19 on a company: 6 questions for the Chief Financial Officer of Johnson & Johnson

      When you’re the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it’s a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.

      Cancer scientist Lewis Cantley, Ph.D., wins the 2020 Dr. Paul Janssen Award for biomedical research

      Cancer. Diabetes. Autoimmune diseases. They’re the common illnesses we have a better chance at fighting, thanks to Dr. Cantley’s pioneering work. Learn more about his “magic molecule” research.